Investigating how a specific pathway affects immune response in pancreatic cancer
Role of MNK kinase pathway in regulating tumor immune microenvironment in pancreatic cancer
This study is looking at how a specific pathway in the body affects the immune system's ability to fight pancreatic cancer, especially focusing on a type of immune cell called CD8+ T cells, and aims to find ways to help these cells better enter and work against tumors, which could lead to better treatments for patients.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Jesse Brown VA Medical Center NIH-funded |
| Lab location | 1 site (Chicago, United States) |
| Project ID | NIH-10881722 on NIH RePORTER |
What this research studies
This research focuses on understanding how the MNK kinase pathway influences the immune environment in pancreatic cancer, particularly how it affects the infiltration and function of CD8+ T cells, which are crucial for fighting tumors. The researchers aim to identify mechanisms that limit T cell entry into tumors and how this pathway interacts with tumor-associated macrophages, which can suppress immune responses. By targeting this pathway, the study seeks to enhance the effectiveness of existing therapies and improve patient outcomes.
Who could benefit from this research
Good fit: Ideal candidates for this research are patients diagnosed with pancreatic ductal adenocarcinoma who are seeking innovative treatment options.
Not a fit: Patients with other types of cancer or those who are not diagnosed with pancreatic cancer may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new treatments that enhance the immune response against pancreatic cancer, potentially improving survival rates for patients.
How similar studies have performed: Other research has shown promising results in targeting immune pathways to enhance anti-tumor responses, suggesting that this approach could be effective.
Where this research is happening
Chicago, United States
- Jesse Brown VA Medical Center — Chicago, United States (Active)
Researchers
- Principal investigator: Munshi, Hidayatullah G. — Jesse Brown VA Medical Center
- Study coordinator: Munshi, Hidayatullah G.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.